2026年3月最新《新锐期刊分区表》数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
体验更多LetPub AI科研工具 >> | |
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 新 聚合物期刊JPM征稿｜IF持续上升 + APC折扣 | 热 Springer Nature特刊征稿 |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | CANCER RESEARCH CANCER RES （此期刊被最新的JCR期刊SCIE收录） LetPub评分 9.3
64人评分
我要评分
声誉 9.8 影响力 8.9 速度 8.9 | |||||||||||||||||||||
| 期刊ISSN | 0008-5472 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||
| E-ISSN | 1538-7445 | |||||||||||||||||||||
| 2024-2025最新影响因子 （数据来源于搜索引擎） | 16.6 点击查看影响因子趋势图 | |||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日：21.4 | |||||||||||||||||||||
| 2024-2025自引率 | 0.6%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年影响因子 | 13.4 | |||||||||||||||||||||
| JCI期刊引文指标 | 2.31 | |||||||||||||||||||||
| h-index | 411 | |||||||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | http://cancerres.aacrjournals.org/ | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
| 期刊投稿网址 | http://can.msubmit.net/cgi-bin/main.plex | |||||||||||||||||||||
| 该期刊中国学者近期发文 - New | KH617 API manufacturing: A synthetic biology approach Author: Zhou, Yi; Liu, Jiong-Qin; Gao, Cheng-Guo; Luo, Hao; Zhao, Man-Xi; Ke, Xiao Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 8, pp. LB033-LB033. DOI: 10.1158/1538-7445.AM2026-LB033 Cytomegalovirus reactivation orchestrates myeloid reprogramming to drive brain metastasis progression Author: Zhao, Hong; Dong, Wenjuan; Xu, Shan; Wang, Shiruo; Puri, Akshjot; Vasquez, Matthew; Gao, Dongbing; Yu, Xiaohui; Cui, Johnny; Lau, Johnson; Sampson, James; Sannes, Caitlin; Chang, Jenny; Wong, Stephen Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 8, pp. -. DOI: 10.1158/1538-7445.AM2026-LB256 Preclinical evaluation of a novel orally bioavailable MDM2 PROTAC, NW-8-461, in acute leukemia and myelofibrosis Author: Zhang, Qinhong; Xu, Yajing; Wu, Qiong; Tu, Cecilia Z.; Wang, Shijia; Yin, Kai; Xu, Xuesong; Zhang, Zhang; Dai, Bing; Tan, Fenlai; Chen, Yi Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 8, pp. LB038-LB038. DOI: 10.1158/1538-7445.AM2026-LB038 Pharmacodynamic (PD) characterization of BGB-24714, a second mitochondrial-derived activator of caspases (SMAC) mimetic, in a first-in-human study in solid tumors Author: Zhang, Jinhui; Deng, Minjuan; Jiang, Bin; Li, Jie; Wang, Judy; Hamilton, Erika; Gao, Hua-Xin; Song, Xiaomin; Shen, Zhirong; Jin, Wei; Donate, Fernando Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 8, pp. -. DOI: 10.1158/1538-7445.AM2026-CT121 | |||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足CANCER RESEARCH的语言要求，还能让CANCER RESEARCH编辑和审稿人得到更好的审稿体验，让稿件最大限度地被CANCER RESEARCH编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评（2篇） 论文致谢（6篇） 。
提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||
| 通讯方式 | AMER ASSOC CANCER RESEARCH, 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404 | |||||||||||||||||||||
| 出版商 | American Association for Cancer Research Inc. | |||||||||||||||||||||
| 涉及的研究方向 | 医学-肿瘤学 | |||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | Semimonthly | |||||||||||||||||||||
| 出版年份 | 1941 | |||||||||||||||||||||
| 年文章数 | 268点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 25.93% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 93.66% | |||||||||||||||||||||
| WOS期刊JCR分区 （ 2024-2025年最新版） | WOS分区等级：1区
| |||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||
  | ||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0008-5472%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 平均2.5月 | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 约30% | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在CANCER RESEARCH顺利发表。
快看看作者怎么说吧：服务好评（2篇） 论文致谢（6篇） 。 提交文稿 | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | KH617 API manufacturing: A synthetic biology approach Author: Zhou, Yi; Liu, Jiong-Qin; Gao, Cheng-Guo; Luo, Hao; Zhao, Man-Xi; Ke, Xiao Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 8, pp. LB033-LB033. DOI: 10.1158/1538-7445.AM2026-LB033 DOI |
| 2. | Cytomegalovirus reactivation orchestrates myeloid reprogramming to drive brain metastasis progression Author: Zhao, Hong; Dong, Wenjuan; Xu, Shan; Wang, Shiruo; Puri, Akshjot; Vasquez, Matthew; Gao, Dongbing; Yu, Xiaohui; Cui, Johnny; Lau, Johnson; Sampson, James; Sannes, Caitlin; Chang, Jenny; Wong, Stephen Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 8, pp. -. DOI: 10.1158/1538-7445.AM2026-LB256 DOI |
| 3. | Preclinical evaluation of a novel orally bioavailable MDM2 PROTAC, NW-8-461, in acute leukemia and myelofibrosis Author: Zhang, Qinhong; Xu, Yajing; Wu, Qiong; Tu, Cecilia Z.; Wang, Shijia; Yin, Kai; Xu, Xuesong; Zhang, Zhang; Dai, Bing; Tan, Fenlai; Chen, Yi Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 8, pp. LB038-LB038. DOI: 10.1158/1538-7445.AM2026-LB038 DOI |
| 4. | Pharmacodynamic (PD) characterization of BGB-24714, a second mitochondrial-derived activator of caspases (SMAC) mimetic, in a first-in-human study in solid tumors Author: Zhang, Jinhui; Deng, Minjuan; Jiang, Bin; Li, Jie; Wang, Judy; Hamilton, Erika; Gao, Hua-Xin; Song, Xiaomin; Shen, Zhirong; Jin, Wei; Donate, Fernando Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 8, pp. -. DOI: 10.1158/1538-7445.AM2026-CT121 DOI |
| 5. | Towards a platform PBPK-QSP model for first-in-human dose selection of GenSci139, a potential best-in-class EGFR×HER2 bispecific ADC, in patients with cancer Author: Zhang, Fan; Xie, Yehua; Ma, Guangli; Liang, Xiao; Zhao, Xumin; Lin, Yihui; Ye, Xuan; Qi, Peng; Wang, Xiaozhen; Zhang, Haizhou; Zhang, Shu; Wang, Siqin; Jin, Lei Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 8, pp. -. DOI: 10.1158/1538-7445.AM2026-LB441 DOI |
| 6. | Whole body PBPK/PD modeling to support first-in-human dose selection for GenSci140, a potential best-in-class FRα biparatopic ADC, in patients with cancer Author: Zhang, Fan; Xie, Yehua; Ma, Guangli; Liang, Xiao; Zhao, Xumin; Lin, Yihui; Ye, Xuan; Qi, Peng; Wang, Xiaozhen; Zhang, Haizhou; Zhang, Shu; Wang, Siqin; Jin, Lei Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 8, pp. -. DOI: 10.1158/1538-7445.AM2026-LB442 DOI |
| 7. | AI guided engineering of pH responsive antibodies enables tumor selective targeting and improves the therapeutic index Author: Yu, Qilin; Chen, Mingchen; Lu, Ying; Wang, Yuxi Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 8, pp. LB027-LB027. DOI: 10.1158/1538-7445.AM2026-LB027 DOI |
| 8. | TCE-A: An OR-gate CD19×CD20×CD3 trispecific T-cell engager for B-cell malignancies and autoimmune diseases Author: Ying, Hanxiao; Wu, Emily; Duan, Sizhu; Bai, Dongmei; Wang, Jing; Pu, Pu; Zhang, Limin; Wang, Chunyue; Hu, Min; He, Feng Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 8, pp. -. DOI: 10.1158/1538-7445.AM2026-LB270 DOI |
| 9. | A phse 1 study of CAN2109, a novel,long-acting, tumor-retained, immunoegenic cell death inducer Author: Yao, Herui; Li, Ning; Yu, Henry Ninghui; Massimini, Giorgio; Zhao, Jianli; Wang, Shuhang; Zhao, Yiming; Yu, Yue; Lai, Xiuping; Lv, Xiaozhi; Wang, Shaoshan; Guo, Xia; Huang, Jiancheng; Tan, Fei; Song, Erwei Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 8, pp. CT074-CT074. DOI: 10.1158/1538-7445.AM2026-CT074 DOI |
| 10. | Orally bioavailable BCL6 degrader HSK47977 featuring a novel CRBN ligand demonstrates potent antitumor activity and synergy with BCL2 inhibition in NHL Author: Xu, Jun; Meng, Qingyuan; Liao, Yuting; Zhang, Chen; Wei, Jing; Tang, Ruofeng; Dou, Caixia; Yang, Jie; Tang, Pingming; Chen, Zhen; Lu, Yao; Wang, Ju; Yan, Pangke Journal: CANCER RESEARCH. 2026; Vol. 86, Issue 8, pp. LB039-LB039. DOI: 10.1158/1538-7445.AM2026-LB039 DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共446条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
